Webinar: Antibody Discovery Platforms and RenMab Mouse_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Webinar,Antibody,Discovery,Platforms,and,RenMab,Mouse

top

Please input keywords

ニュース&PR

お問い合わせ

JP

私たちの歩み

管理スタッフ

社会的責任

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

動物・細胞モデル

Pharmacology service

ゲノム編集

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

ウェビナー

Humanized CD47 Mice: Efficacy and Safety Evaluation of Anti-CD47 Antibody Drugs In Vivo

2021.09.13

Humanized CD47 Mice:
Efficacy and Safety Evaluation of Anti-CD47 Antibody Drugs In Vivo

Prev:Humanized CD3 Models: Efficacy...

Next:BIO KOREA 2021 Company present...